
Olmirose Trio 40mg/10mg/6.25mg Tablet
Marketer
Thyone Health Care
Salt Composition
Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)
Overview Olmirose Trio 40mg/10mg/6.25mg Tablet
HCTZ-Olmesartan-Amlodipine 40mg/10mg/6.25mg tablets combine three medications to effectively manage hypertension when monotherapy proves insufficient. This triple therapy lowers elevated blood pressure, significantly reducing the risk of future strokes and heart attacks. Administer this medication with food, at the same time daily, and as directed by your physician. Continue treatment as prescribed; discontinuation may increase stroke or heart attack risk. This combination includes a diuretic, increasing urination; avoid dosing within four hours of bedtime. Consistent use, even feeling well, maximizes benefits. Hypertension often lacks noticeable symptoms. Common side effects include edema, cephalalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to mitigate potential muscle weakness, xerostomia, and polydipsia. Prior to commencing treatment, inform your physician of any pre-existing kidney or liver conditions, pregnancy, breastfeeding, or concurrent medications, especially those for hypertension or heart disease. Regular monitoring of blood pressure, renal function, electrolyte levels, and blood glucose is essential to ensure treatment efficacy and safety.
Primary Ingredients of Olmirose Trio 40mg/10mg/6.25mg Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Olmirose Trio 40mg/10mg/6.25mg Tablet
Elevated arterial pressure
Major Benefits of Olmirose Trio 40mg/10mg/6.25mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Olmirose Trio 40mg/10mg/6.25mg tablets with food.
Common Side effects of Olmirose Trio 40mg/10mg/6.25mg Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Olmirose Trio 40mg/10mg/6.25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The Olmirose Trio 40mg/10mg/6.25mg Tablet should be administered with a meal.
How Olmirose Trio 40mg/10mg/6.25mg Tablet works:
Olmirose Trio tablets (40mg/10mg/6.25mg) contain telmisartan, cilnidipine, and chlorthalidone. Telmisartan, an angiotensin receptor blocker (ARB), and cilnidipine, a calcium channel blocker (CCB), act synergistically to dilate blood vessels, thus reducing blood pressure. Chlorthalidone, a diuretic, facilitates the excretion of excess fluid and electrolytes, contributing to lower blood pressure and improved circulation via vasodilation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Olmirose Trio 40mg/10mg/6.25mg tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Olmirose Trio 40mg/10mg/6.25mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known risks. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Olmirose Trio 40mg/10mg/6.25mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Olmirose Trio 40mg/10mg/6.25mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmirose Trio 40mg/10mg/6.25mg tablets, as dose modification may be necessary. A physician's consultation is advised. This medication is generally not recommended for such individuals.
LiverCAUTION
Patients with liver impairment should use Olmirose Trio 40mg/10mg/6.25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Olmirose Trio 40mg/10mg/6.25mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Olmirose Trio 40mg/10mg/6.25mg Tablet :
Should you forget a dose of Olmirose Trio 40mg/10mg/6.25mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmirose Trio 40mg/10mg/6.25mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
